In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21 WAF1/Cip1 than did control clones. The level of p21 WAF1/Cip1 expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21 WAF1/Cip1 transcriptionally silent.
Introduction
Interferons (IFNs) are known to modulate expression of a number of proteins that mediate their antiproliferative and antitumor activities (Pestka et al., 1987) . The signal transduction cascades leading to expression of proteins involved in growth regulation are initiated by binding of IFNs to their cell surface receptors. Type I IFNs (IFNa, IFNb, IFNo, and IFNt) all act via binding to the same receptor (Stewart et al., 1987) . Upon receptor engagement, the JAK1 and TYK2 tyrosine kinases phosphorylate STAT-1a, -1b and STAT-2 proteins. These activated STAT proteins, together with p48, form the IFN-stimulated gene factor 3 (ISGF3) complex. ISGF3 can then bind to conserved sequences present in the promoter of type I IFNresponsive genes, IFN-stimulated response elements (ISRE) (Darnell et al., 1994) . In addition to STAT proteins, members of the IFN regulatory factor (IRF) family of transcription factors are induced and activated in response to interaction of type I IFNs with their receptors. The IRF family includes, among others, IRF-1, IRF-2, IRF-3, IFR-4, IFN consensus sequence binding protein (ICSBP) and p48 (Harada et al., 1998; Pitha et al., 1998) . IRF-1 and p48, act as transcriptional activators while others, such as IRF-2 and ICSBP, function as repressors. All of these factors exhibit high homology in their DNA-binding domains (DBD) and interact with a conserved element, termed, IRF-E.
Numerous studies have indicated that the regulation of cell growth depends on the ratio between IRF-1 and IRF-2, and any change that interferes with the balance of these two factors can result in a signi®cant eect on cell growth (Taniguchi et al., 1995; Kirchho et al., 1993; Tanaka et al., 1994) . Over expression of IRF-2 in NIH3T3 cells results in oncogenic transformation of the cells, which revert to non-transformed phenotype when IRF-1 is over expressed (Harada et al., 1993) . The presence of IRF-1 is critical for expression of some IFNinducible genes. For example, induction of both guanylate binding protein and inducible nitric oxide synthase is IRF-1-dependent (Matsuyama et al., 1993) . In contrast, IFN-induced expression of other genes, such as RNA-dependent protein kinase (PKR) and 2'5' oligoadenylate synthetase (2'5' OAS), both of which in¯uence cell growth (Meurs et al., 1993; Koromilas et al., 1992; Rysiecki et al., 1989; Hassel et al., 1993) , appears to be independent of the IRF-1-mediated pathway of transcriptional activation. It has been suggested that despite the lack of signi®cant eect of IRF-1 on induction of these genes, their expression may be in¯uenced by alterations in the IRF-1:IRF-2 balance during the cell cycle .
The passage of the cell from one phase of the cell cycle to another is dependent on the activation and subsequent inactivation of the cyclins and their inhibitors. p21 WAF1/Cip1 is a universal cyclin dependent kinase (Cdk) inhibitor (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993) . Paradoxically, it has also been shown to be important in the activation of Cdks. Low levels of p21 WAF1/Cip1 expression prompt the association of cyclins and their kinases into active complexes, while high levels of p21 WAF1/Cip1 result in formation of a complex containing multiple p21 WAF1/Cip1 subunits with inactivation of Cdks (Zhang et al., 1994) . The promoter of p21 WAF1/Cip1 has been found to have a number of IRF-1 binding sites (Taniguchi et al., 1995) . The p21 WAF1/Cip1 gene is also regulated by p53, and an IRF-1 binding site has also been found in the promoter region of the p53 gene, which has an important role in growth regulation and the cell cycle . Control of p21 WAF1/Cip1 expression by the IRF-1:IRF-2 balance may further explain their respective antioncogenic and oncogenic potentials.
Because of the important role of IFNs in controlling cell growth and the clinical implication of this function, we were interested in investigating the involvement of the IRF family of proteins in the regulation of genes controlling cell growth and the cell cycle. We established a cellular model system for examination of IRF family-mediated transcriptional regulation of IFN inducible genes. The system involved cloning of the IRF-2 DBD, without the C-terminal regulatory domain. The IRF-2 DBD was stably transfected into U937 cells, creating a dominant negative mutant in which the ISRE was occupied by the transcriptionally inactive IRF-2 DBD. The eect of the DBD expression on genes involved in growth regulation, speci®cally p21
, was examined.
Results

IRF-2 DBD proteins bind ISRE
The ability of the E. coli-expressed and puri®ed IRF-2 DBD proteins to bind to ISRE sequences was tested by using ISRE from two dierent sources, GBP and ISGF15. The GBP (ISRE) 3 oligonucleotide consisted of three copies of the GBP ISRE. When incubated with either DBD-129 or DBD-114, three bands appeared ( Figure 1a ) which represent three dierent complexes of the GBP ISRE with the DBDs. When the amount of DBD protein was reduced by 30-fold, only the single lower band, consisting of only one ISRE site occupied by the DBD, was observed (data not shown). Anti-DBD antibodies supershifted all three of the complexes, indicating that all three contain DBD. Addition of prebleed did not change the pattern of the three complexes, demonstrating the speci®city of the interaction between anti-DBD and the complexes. Incubation of a single copy of the ISGF-15 ISRE with DBD-129 or DBD-114 resulted in the formation of one complex (Figure 1b) . The slight dierence in mobility observed in complexes using the two DBD likely re¯ects the dierent molecular weights of the two proteins. Anti-DBD antibodies again supershifted the complexes, indicating that they include the IRF-2 DBD.
Analysis of competition for ISRE binding to IRF-2 DBD proteins was carried out using cold ISGF-15 ISRE ( Figure 2a ) and an unrelated promoter element (Figure 2b) . Dilution of the 32 P ISGF-15 ISRE oligonucleotide with a tenfold molar excess of cold ISGF-15 ISRE failed to inhibit binding of IRF-2 DBD, which may be attributable to an excess of DBD protein in the reaction. In contrast, a 100-fold molar excess of cold ISGF-15 ISRE produced a signi®cant decrease in 32 P ISGF-15 ISRE binding the DBD proteins (Figure 2a) . Addition of the unrelated promoter element, UCR, at the same molar ratio of 1 : 100 (Figure 2b ) did not aect 32 P ISGF-15 ISRE binding to the IRF-2 DBDs. Thus, both the IRF-2 DBD-114 and DBD-129 bind speci®cally to ISRE.
Transient cotransfection of U937 with the IRF-2 DBD-114 or DBD-129, an IRF-1 expression vector, and an ISRE-luciferase reporter construct indicated that the IRF-2 DBD inhibits IRF-1 induction of ISREdependent luciferase activity (Figure 3 ). The extent of inhibition of IRF-1-driven ISRE activity was correlated with the amount of DBD used for transfection. Yet some residual reporter activity could be observed even with the use of 10 mg of the IRF-2 DBD-129. Expression of the IRF-2 DBD did not inhibit activity of an unrelated retinoic acid responsive reporter (data not shown). Therefore, the IRF-2 DBD not only binds to the ISRE, but it inhibits gene activation in response to IRF-1.
IRF-2 DBD stable transfectants exhibit growth inhibition
The pre-monocytic cell line, U937, was stably transfected with either the IRF-2 DBD-129 or the . Clones #4 and #16 expressed relatively low levels of the DBD. Clones #14 and especially #13 expressed high levels of the DBD. Clone #9, transfected with the empty vector, and untransfected U937 cells did not express detectable IRF-2 DBD. In control and DBD clones, the levels of endogenous IRF-2 were not measurable altered. The growth rates of the four IRF-2 DBD clones were compared with the growth rate of the control clone (#9) and the parental U937 cells ( Figure 5 ). There was a positive correlation between the level of growth inhibition of the clones and the level of IRF-2 DBD expressed. Clones expressing high levels of DBD, clone #13 and #14, exhibited the highest level of growth inhibition, while clones that expressed low levels of DBD, clone #4 and #16, showed lower levels of growth inhibition. Clone #13 was not employed for further examination due to extremely slow growth, and clone #14 was used as the representative high DBD-expressing clone. Both clones #13 and #14 also exhibited morphological alterations consistent with growth inhibition. Cell enlargement and development of giant cells were observed ( Figure 6 ). Cell cycle analysis indicated that in those clones expressing high DBD levels there was an increased percentage of cells with DNA content less than that of the G1 peak, which is indicative of apoptotic or dying cells (Table 1) . Thus, high IRF-2 DBD-expressing clones appear to exhibit reduced viability. In addition, when adjusted for the percentage of cells in the sub G1 population, the percentage of the clone #13 cells in S and G2/M phases of the cell cycle was increased relative to the clone control and the parental cells. Thus, the slow growth rate of the high DBD-expressing clones may be a function of retarded progression through S and G2/M.
Elevated p21
WAF1/Cip1 expression in IRF-2 DBD transfectants p21 WAF1/Cip1 has been reported to be an important factor in cell growth regulation and dierentiation (Zhang et al., 1995) . The basal level of p21 WAF1/Cip1 mRNA was signi®cantly increased in IRF-2 DBD stable transfectants (Figure 7) . Expression of p21 WAF1/Cip1 was also positively correlated with the level of DBD expression, since the high DBD-expressing clone #14 expressed the highest level of p21 WAF1/Cip1 . The same results were obtained with immunoblots, indicating that protein levels were consistent with those of message (data not shown).
As a Cdk inhibitor, p21
is involved in formation of a quaternary complex with three other components that regulate cell cycle progression, cyclin A, Cdk2 and PCNA (Zhang et al., 1994) . Since DBD expression was associated with altered p21 WAF1/Cip1 expression, the eect of IRF-2 DBD on expression of these additional growth regulatory proteins was Figure 4 Immunoblot detection of the IRF-2 DBD in stable clones. Four clones expressing dierent levels of IRF-2 DBD were selected. Nuclear extracts (30 mg) were resolved on 18% SDS ± PAGE and blotted into PVDF membrane. IRF-2 DBD protein and native IRF-2 were detected using anti-DBD Ab by ECL. The untransfected U937 control is indicated by`co' Figure 5 Growth curve of DBD clones. Cells were cultured in the appropriate medium for 6 days, and viable cell counts were determined by Trypan blue dye exclusion. The data represent the mean of three replicate experiments Figure 6 Morphology of DBD clones. Cells were plated at 1610 6 cells/ml and incubated for 3 days. Cells were photographed at 20-fold magni®cation and then printed at 200-fold magni®cation ) were cultured for 3 days, collected, stained with propidium iodide and analysed by¯ow cytometry. Control is the parental U937 cell line and clone #9 was transfected with empty vector. Representative data from one of the three replicate experiments are presented as the percentage of cells in each phase of the cell cycle. Values in parentheses represent percentages adjusted for the sub G0/G1 population examined. There was a positive correlation between the level of IRF-2 DBD expression and the level of cyclin A and Cdk2 (Figure 8 ). Cyclin A was increased in the high DBD-expressing clone #14, while the Cdk2 protein was signi®cantly increased in all IRF-2 DBD transfectants. PCNA expression did not appear to be modulated by the IRF-2 DBD. Thus, three of four proteins involved in an important growth regulatory complex are aected by the IRF-2 DBD.
To assess whether the increase in basal expression of p21 WAF1/Cip1 in these clones was unique to the DBD of IRF-2 or representative of a common eect of the IRF family, p21 WAF1/Cip1 expression was examined in previously characterized clones stably transfected with the DBD of another negative regulatory member of the IRF family, interferon consensus sequence binding protein (ICSBP; Thornton et al., 1996) . Northern analysis of p21 WAF1/Cip1 expression in ICSBP DBD stable transfectants also revealed increased basal expression (Figure 9 ).
Discussion
We have used a dominant negative approach to study the role of the IRF family in mediating growth regulation. Stable transfectants of U937 cells were produced expressing 129 aa of the amino terminus IRF-2, which constitute its DBD alone. The IRF-2 DBD is sucient to bind to the ISRE, yet it lacks repressor function. The balance between IRF-1 and IRF-2 is important for regulation of cell proliferation, and both IRF-1 and IRF-2 bind with the same anity to the same site within the ISRE . In the dominant negative mutant, overexpression of the IRF-2 DBD alone, lacking the repressor function, would compete with wild-type IRF-2. The observed up-regulation of p21 WAF1/Cip1 gene expression in the IRF-2 DBD clones can be attributable to abrogation wild-type IRF-2 repression, where the level of p21 WAF1/Cip1 was positively correlated with the level of expressed DBD. In fact, negative control of IFNinducible genes in the absence of IFN induction has been previously suggested as a mechanism of transcriptional regulation by Taniguchi (Harada et al., 1993; Taniguchi et al., 1995) . An alternative mechanistic explanation is that when the DBD binds to the DNA, it changes the conformation of the chromatin such that it makes regions of the promoter more accessible to enhancers with nearby binding sites (Wole, 1994) . The promoter region of p21 WAF1/Cip1 does contain binding sites for a variety of additional activators among them, Sp1 (Biggs et al., 1996) , VDR (Liu et al., 1996) , Ets, and p53 (Macleod et al., 1995) in addition to the ISRE. Increased basal levels of p21 WAF1/Cip1 expression were also found in the ICSBP DBD clones, indicating that this observation represents the eect of the DBDs of the IRF family, not just the eect of the DBD of IRF-2.
Since p21 WAF1/Cip1 is involved in the assembly of cyclin/Cdk4 complexes, and expression of cyclin A and Cdk2 is also increased in the DBD clones, the IRF family may regulate these kinase complex components, as well. p21 WAF1/Cip1 concentrations modulate association of cyclin A, Cdk2, and PCNA into an active kinase complex. A low level of p21 WAF1/Cip1 promotes assembly of active kinase complexes, while at high p21 WAF1/Cip1 concentrations, kinase activity is inhibited (Zhang et al., 1994) . Thus, the increased p21 WAF1/Cip1 expression in the DBD clones facilitates formation of inactive complexes and cell cycle arrest. p21 WAF1/Cip1 also inhibits DNA replication by binding and sequestering PCNA (LaBaer et al., 1996) . Our data indicate that overexpression of the IRF-2 DBD did not aect expression of PCNA. PCNA expression has been shown not to impede inhibition of kinase activity by p21 WAF1/Cip1 (Zhang et al., 1994) . Since p21 WAF1/Cip1 is known to inhibit Cdks, elevated p21 WAF1/Cip1 expression may contribute to the growth inhibition observed in the IRF-2 DBD transfectants.
The altered gene expression in the DBD clones has functional consequences for cell growth. Changes in Figure 7 Expression of p21 WAF1/Cip1 in IRF-2 DBD clones. Total RNA (12 mg) was electrophoresed on a 1.2% formaldehyde/ agarose gel, blotted into Hybond N membrane and hybridized with 32 P-labeled p21 WAF1/Cip1 cDNA. rRNA served as an internal marker. The control, labeled Co-, is the parental U937 cell line Figure 8 Immunoblot analysis of cyclin A, Cdk2, and PCNA. Whole cell extract (30 mg) was electrophoresed on 4 ± 20% SDS ± PAGE, and blotted into PVDF membrane. Proteins were detected using the appropriate polyclonal antibodies and developed by ECL. The control, labeled Co-, is the parental U937 cell line Figure 9 p21 WAF1/Cip1 expression in ICSBP-DBD clones. Total RNA (12 mg) from U937 cells (Control), IRF-2 DBD and ICSBP DBD clones (Thornton et al., 1996) was electrophoresed on a 1.2% formaldehyde/agarose gel, blotted into Hybond N membrane and hybridized with 32 P-labeled p21 WAF1/Cip1 cDNA growth characteristics of IRF-2 DBD-expressing clones were demonstrated by decreased proliferation, morphological changes, and an increase in cell death or apoptosis. The extent of expression of each of these parameters was positively correlated with of level of DBD expressed. A reduced growth rate with slower progression through S and G2/M has been previously observed in ICSBP DBD clones (Thornton et al., 1996) . Consistent with derepression of p21
expression by the IRF-2 DBD, elevated p21
has been implicated in IFN-induced growth arrest (Chin et al., 1996) . Daudi cells exhibited a profound increase in proliferation and elevated p21
expression within 16 ± 20 h after type I IFN treatment (Subramaniam and Johnson, 1997) . The U937 cells used for our studies are less responsive to the antiproliferative activity of type I IFNs, Rubinstein and Pontzer (submitted), and do not exhibit the same IFN-induced increase in p21
. This is due to the combination of lack of p53 expression, so that p21 WAF1/ Cip1 is expressed only in a p53-independent fashion (Biggs et al., 1996; Sugimoto et al., 1992) , and deletion of one IRF-1 gene in U937 cells (Beretta et al., 1996) .
Since overexpression of the IRF-2 DBD mutant results in an increase in the basal level of p21
, we have identi®ed active repression by IRF-2 which is required to keep p21 WAF1/Cip1 transcriptionally silent. Derepression of p21 WAF1/Cip1 expression results in slower growth of IRF-2 DBD cells. Thus, a gene central to growth control is under the basal regulation of the IRF family. The IRF-1:IRF-2 balance, though, is only one component of a complex growth regulatory system, and this system is susceptible to modulation by IFN treatment. In addition, viruses may alter growth control through virally-encoded IRFs that suppress p21 WAF1/Cip1 gene transcription (Gao et al., 1997) . The IRF-2 DBD dominant negative mutants should serve as an important tool to further decipher the function of the IRF family in regulation of cell growth and understand the complex mechanisms by which IFNs and viruses aect cell proliferation.
Materials and methods
Cells
U937 human premonocyte lymphoma cells were cultured in RPMI 1640 supplemented with 10% FBS, 2 mM glutamine, 50 mg/ml gentamicin sulfate, and 50 mM b-mercaptoethanol.
IRF-2 DBD expression in E. coli
Two PCR products of 342 and 487 nucleotides of the IRF-2 DBD with NdeI and BamHI restriction sites attached to each end, representing 114 and 129 aa, respectively, of the IRF-2 N-terminus were generated using a plasmid expressing fulllength IRF-2 and the following primers: PCR products were double digested with NdeI and BamHI and inserted into pET-15b (Novagen, Madison, WI, USA). Vectors with either the 129 aa form or 114 aa form of the IRF-2 DBD insert were used to transform the BL21 (lDE3)pLysS strain of E. coli. Expression was induced by 1 mM IPTG in conjunction with 150 mg/ml rifampicin. After 3 h, the cells were lysed by sonication, centrifuged, and the protein puri®ed from the cell lysate using a Ni-NTA agarose column (Qiagen, Chatsworth, CA, USA). Following puri®ca-tion, each product ran as a single band on 18% SDS ± PAGE gels.
Antibodies
Polyclonal antisera against the puri®ed IRF-2 DBD proteins were raised by injection of rabbits with 25 mg of each puri®ed protein in three consecutive injections with intervals of 3 weeks. Antisera titers were greater than 10 000 as determined by indirect ELISA. Polyclonal antisera to p21 WAF1/Cip1 , cyclin A, Cdk2, and PCNA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Electrophoretic mobility shift assays (EMSA)
The oligonucleotide probes for the ISRE, one of which was derived from the ISG15 gene and the other consisting of three copies of the guanylate binding protein ISRE (GBP (ISRE) 3 ), and the upstream conserved region (UCR) of the murine leukemia virus which was used as a control, have been described previously (Flanagan et al., 1992) . Annealed oligonucleotides (10 pmol) were labeled with 5 ml of g-32 P-ATP (speci®c activity 5000 Ci/mmol) using polynucleotide T4 kinase (USB, Cleveland, OH, USA) in 20 ml ®nal volume at 378C for 30 ± 45 min. Unincorporated 32 P-ATP was removed using a G-25 column (5 prime 3 prime, Boulder, CO, USA). The EMSA reaction was performed using 3 ml of 56 EMSA binding buer (20 mM HEPES, 50 mM KCl, 10% glycerol, 0.5 mM DTT, 0.1 mM EDTA, 1 mM MgCl 2 ), 1 ml poly dI-dC (2 mg/ml), 1 ml herring sperm DNA (1 mg/ml) and 4 ± 10 mg of puri®ed IRF-2 DBD (114 aa) or DBD (129 aa) protein. Antiserum (2 ml) or a 100-fold molar excess of unlabeled competitor oligomers were added where indicated. The reaction mixture was brought to 14 ml with dH 2 O and incubated at RT for 5 ± 10 min. One ml of labeled probe (5610 4 c.p.m.) was added, and the reaction was incubated for an additional 15 ± 20 min. The reaction products were separated on a 8% polyacrylamide gel.
Construction of the eukaryotic expression vector
An IRF-2 DBD product, representing the 129 aa form, with XhoI sites attached at each end was generated by PCR. The primers used were: An expression plasmid for the dominant negative IRF-2 DBD was constructed by cloning the insert into the XhoI site of pCXN2, which is a 5.2 Kb vector based on puc-19 (Niwa et al., 1991) .
Luciferase reporter assay
U937 cells (1610 7 ) were cotransfected by electroporation with 10 mg of ISRE-luciferase reporter, 10 mg of the IRF-1 expression vector, pAct-1 (a gift from T Taniguchi), with or without 20 mg of either the DBD-114 or DBD-129 expression vector. The ISRE-luciferase reporter construct consisted of GBP (ISRE) 3 fused in front of the 40-bp basal promoter of the L d gene and cloned into the pGL2 luciferase plasmid. The luciferase reporter without the ISRE insert and an unrelated retinoic acid-responsive reporter were used as controls. Cells were incubated for 18 ± 20 h until harvest.
Transfection and cloning of stable transfectants U937 cells (1610 7 ) were transfected with 50 mg of control pCXN2 (no insert), or pCXN2 containing the IRF-2 DBD insert by electroporation. Cells were selected with geneticin (200 mg/ml, Life Technologies) for 2 weeks and cloned by limiting dilution. Forty IRF-2 DBD clones and 20 pCXN2 clones were isolated and screened for IRF-2 DBD expression by Western blot. From that pool, four clones expressing dierent levels of the IRF-2 DBD (#4, #13, #14, #16) and one control clone (#9) containing the empty vector were selected.
Immunoblot analysis
Cells (1610 6 ) were incubated for 3 min on ice in 0.5 ml of lysis buer (10 mM Tris, pH 7.5, 10 mM NaCl, 15 mM MgCl 2 , 1 mM AEBSF and 0.05% Nonidet P-40) (Antalis and Godblot, 1991) . Nuclei were pelleted, washed, and extracts were prepared by shaking for 30 min at 48C in 50 ± 100 ml of buer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM AEBSF) (Schreiber et al., 1989) . Nuclear or whole cell extracts (30 mg) were resolved on SDS ± PAGE and electroblotted to PVDF membrane (Novex, San Diego, CA, USA). The membranes were reacted with the appropriate primary antibodies diluted in PBS containing 0.1% Tween 20. Peroxidase-coupled goat anti-rabbit IgG was employed for detection according to the ECL protocol provided by the manufacturer (Amersham, Arlington Heights, IL, USA).
RNA blot analysis
Total RNA was extracted using RNAzol (Tel-Test, Friendswood, TX, USA). RNA (12 mg) was electrophoresed through a 1.2% formaldehyde agarose gel and blotted into Hybond-N membrane (Amersham) in 206 SCC (3 M NaCl and 0.3 M sodium citrate, pH 7.0). Membranes were hybridized in QuikHyb buer (Stratagene, La Jolla, CA, USA) with 32 Plabeled probes at 688C for 1 h. The p21 WAF1/Cip1 probe (a gift from B Vogelstein) was labeled using the Prime-It RmT kit (Stratagene).
Cell growth
Cells (1610 4 ) were resuspended in 10 ml of complete medium, and cell number was determined every 24 h for 6 days by Trypan blue dye exclusion. For cell cycle analysis, cells (1610 5 /ml) were cultured in complete medium for 3 days, and labeled with 50 mg/ml propidium iodide containing RNase (100 U/ml). Analysis was performed on a FACScan ow cytometer (Becton Dickinson, Mountain View, CA, USA).
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